Zygel Cannabidiol Gel Tolerated Well Up to 21 Months, Trial Data Show

Zygel Cannabidiol Gel Tolerated Well Up to 21 Months, Trial Data Show

315728

Zygel Cannabidiol Gel Tolerated Well Up to 21 Months, Trial Data Show

Zygel, an experimental cannabidiol gel that Zynerba Pharmaceuticals is developing to help normalize behaviors in people with fragile X syndrome, continues to be well tolerated up to a median treatment length of 21 months, according to new data from the open-label extension of the Phase 2/3 CONNECT-FX trial. Results were shared in the presentation “ZYN002 Cannabidiol Transdermal Gel Efficacy and Safety: Recent Clinical Research Advances in the Treatment of Autism and Fragile X Syndrome” at…

You must be logged in to read/download the full post.